Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,063 AUD | -4,55 % |
|
-12,50 % | +186,36 % |
18/04 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 | |
11/04 | Transcript : Nyrada Inc. - Special Call |
Resumen de negocios
Ventas por actividad
AUD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Drug Development
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +36,40 % |
Ventas por región
AUD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +36,40 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
James Bonnar
CEO | Chief Executive Officer | - | 01/02/18 |
Founder | - | 29/08/17 | |
Chief Tech/Sci/R&D Officer | - | - | |
Benjamin Evison
CTO | Chief Tech/Sci/R&D Officer | - | 29/08/17 |
Investor Relations Contact | - | 01/06/23 | |
David Franks
SEC | Corporate Secretary | 53 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Founder | - | 29/08/17 | |
Ruediger Weseloh
BRD | Director/Board Member | - | 01/06/19 |
Marcus Frampton
BRD | Director/Board Member | 44 | 01/06/19 |
John Moore
CHM | Chairman | 59 | 16/07/19 |
Christopher Cox
BRD | Director/Board Member | 59 | 01/11/19 |
Ian Dixon
BRD | Director/Board Member | - | 01/09/20 |
Gisela Mautner
BRD | Director/Board Member | - | 01/08/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 156 008 700 | 111 042 692 ( 71,18 %) | 0 | 71,18 % |
Información de la empresa
![Dirección Nyrada Inc.(NYR)](https://cdn.zonebourse.com/static/address/89519872.png)
Varia. 1 de ene. | Capi. | |
---|---|---|
+186,36 % | 7,95 M | |
+51,82 % | 791 mil M | |
+40,45 % | 630 mil M | |
+16,95 % | 328 mil M | |
+9,49 % | 298 mil M | |
+17,25 % | 246 mil M | |
+0,41 % | 225 mil M | |
+10,22 % | 218 mil M | |
+5,30 % | 160 mil M | |
-6,29 % | 156 mil M |
- Bolsa de valores
- Acciones
- Acción NYR
- Empresa Nyrada Inc.